Real-time enrollment status for this bacterial infection clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 9:45 PM UTC
| NCT Number | NCT06462235 |
| Recruiting Status | Recruiting |
| Condition | Bacterial Infection |
| Phase | PHASE2 |
| Target Enrollment | 48 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | October 15, 2026 (4 days ago) |
As of October 19, 2026: Clinical trial NCT06462235 is currently recruiting participants. This phase2 study for bacterial infection is actively seeking new participants at 11 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06462235 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06462235 was last updated 4 days ago (October 15, 2026). HelloStudys verifies this status automatically.